News for Nuwellis, Inc. (NUWE)

MINNEAPOLIS, June 10, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. ( NUWE) (”œNuwellis” or the ”œCompany”), a commercial-stage medical device company dedicat

Nuwellis (NUWE) has completed a $5 million public offering successfully. Offering includes 2.58 million common shares and 14.09 million pre-fund

Nuwellis (NUWE) announced a public offering that significantly impacted its stock price, dropping shares by 37%. Wall Street analysts set a one-year pri

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday. The Dow traded up 0.04% to 42,779.63 while th...

Nuwellis (NUWE) offers shares and warrants at $0.30 to raise capital for growth.

Nuwellis (NUWE) has set the terms for a public offering that includes 406,755 shares of its common stock, along with pre-funded warrants for 14,085,998 addition

MINNEAPOLIS, June 09, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. ( NUWE) (”œNuwellis” or the ”œCompany”), a commercial-stage medical device company dedicat

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 0.2% on Monday. Following the market opening Monday, the Dow traded down 0.23% t...

Nuwerix, Inc. (NUWE) has appointed Ladenburg Thalmann to assume the role of manager. This strategic collaboration aims to leverage the expertise of Ladenburg Th

PR NewswireNASHVILLE, Tenn., May 29, 2025 Refreshed Board Overseeing Successful Execution of Company's Strategy Ortelius' Candidates Bring No Additive Expe

Operator: Good day, everyone, and welcome to Nuwellis First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.

Revenue: $1.9 million, a 3% increase year over year.Gross Margin: 56%, down from 64.1% in the prior year.Operating Expenses: $4.1 million, a 31% reduction from

May 13, 2025 / 01:00PM GMTOperator Good day, everyone, and welcome to Nuwellis first quarter 2025 earnings conference call. (Operator Instructions) Please note,

Roth Capital's analyst, Jonathan Aschoff, has adjusted the price target for Nuwellis (NUWE) from $13 to $11, although he maintained a Buy rating on the stock. D

Nuwellis (NUWE) delivered earnings and revenue surprises of -53.33% and 23.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuwellis (NUWE) to report Q1 earnings on May 13. Consensus EPS: -$0.45; Revenue: $2.5M.

Nuwellis (NUWE) has entered into a strategic partnership with KDI Precision Manufacturing to support its ongoing growth initiatives. This collaboration aims to

Strategic agreement is expected to reduce costs, preserve expertise, and streamline operations. WHOWHATWHEREWHENWHYNuwellis, Inc. ( NUWE) and KDI Precision Ma

WHOWHATWHEREWHENWHYNuwellis, Inc.Issuance of U.S. Patent No. 12,280,007.United States Patent and Trademark OfficeApril 22, 2025To protect a novel self-emptying